Dublin, July 11, 2024 (GLOBE NEWSWIRE) — The “U.S. Biosensors Market Size, Share & Trends Analysis Report by Technology (Electrochemical, Thermal, Piezoelectric), Application (Medical, Food Toxicity, Bioreactor), End-use, and Segment Forecasts, 2024-2030” report has been added to ResearchAndMarkets.com’s offering.
The market for biosensors in the United States is showing impressive growth projections, with expectations to reach a mark of USD 15.61 billion by the end of the decade. A considerable compound annual growth rate (CAGR) of 7.13% from 2024 to 2030 is indicative of the sector’s robust health and its pivotal role across various applications including medical diagnostics, food safety testing, and environmental monitoring.
Electrochemical biosensors are leading the technology segment, holding a dominant revenue share due to their extensive applications. These sensors, integral to portable devices such as blood glucose meters, have revolutionized personal health monitoring by providing quick and reliable results, essential for conditions like diabetes.
Medical Applications Dominate Market Share
The medical application of biosensors has significantly contributed to the market’s growth, mirroring the sector’s largest share due to the pressing need for rapid and accurate diagnostics. Innovations in biotechnology have furthered the development of cutting-edge diagnostic tools that bolster personalized health regimens, benefitting patients with actionable health data.
Point of Care Testing: A Transformation in Healthcare Delivery
Biosensors are increasingly favored in point-of-care settings, including clinics and emergency departments, which is evidenced by their substantial end-use market share. Their ability to deliver immediate testing results has been transformative in healthcare delivery, providing rapid, yet dependable diagnostics at the patient’s location.
Comprehensive Outlook on Growing U.S. Market
The growth trajectory of the U.S. biosensors market is backed by the continuous need for advanced diagnostic options, coupled with technological advancement and supportive regulations. This positive outlook heralds a dynamic phase for the industry, with extensive contributions to enhanced medical outcomes and healthcare efficiency across the nation.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 80 |
| Forecast Period | 2023 – 2030 |
| Estimated Market Value (USD) in 2023 | $9.64 Billion |
| Forecasted Market Value (USD) by 2030 | $15.61 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | United States |
Companies Featured
- Abbott
- Medtronic
- Hoffmann-La Roche Ltd
- Dexcom, Inc.
- SENTINEL
- Intricon Corporation
- Quanterix
- Koninklijke Philips N.V.
- Masimo
- Siemens Healthcare Private Limited
- Molecular Devices, LLC.
- Johnson & Johnson Services, Inc.
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- Covaris, LLC
For more information about this report visit https://www.researchandmarkets.com/r/ukklwb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
